We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Prof
Jaspal
Kooner
j.kooner@imperial.ac.uk
Prof
Jaspal
Kooner
j.kooner@imperial.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Cerebrovascular diseasesIschaemic heart diseasesDiabetes mellitusMalignant neoplasms of ill-defined, secondary and unspecified sites
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
South Asians living in the UK are at high risk of both cardiovascular disease (CVD) and type-2 diabetes (T2D). The mechanisms are not known. To advance understanding of metabolic, cardiovascular and other important chronic diseases in UK South Asians, we propose to establish LOLIPOP 100K, a longitudinal population study comprising ~100,000 South Asian and European men and women, aged 25-85 years, under long-term follow-up for health outcomes. All participants will complete a structured assessment comprising: i. Registration and consent; ii. Questionnaires (health and lifestyle, cognition and dietary intake); iii. Physical measurements (height, weight, waist, hip, bioimpedance, blood pressure, electrocardiogram, lung function and retinal photograph); iv. Biological samples (blood, urine and stool) and v. Physical activity monitoring. The assessment is expected to take around 90 minutes. Blood samples will be stored at -80°C.
All participants will be followed-up for their health long term through medical and other health-related records. This will include linkage for; i. death; ii. site-specific cancer, iii. Hospital Episode Statistics (HES) for England and Wales; Scottish Morbidity Record (SMR) for Scotland; iv. myocardial infarction (MINAP), stroke (SINAP); v. pathology services; vi. hospital databases ; vii. primary-care health records.
Data and samples will be used to investigate the behavioural, environmental, genetic and other molecular factors influencing health and disease in South Asian populations.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Cohort study;
You can take part if:
You may not be able to take part if:
We seek a representative population sample. The only exclusion criterion are: 1. Current or recent acute illness 2. Unable to give informed consent 3. Known to be pregnant
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Prof
Jaspal
Kooner
j.kooner@imperial.ac.uk
Prof
Jaspal
Kooner
j.kooner@imperial.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by Imperial College of Science, Technology and Medicine and funded by Wellcome Trust .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 44841
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
